Jonathan Drachman

CEO & President, Neoleukin Therapeutics Inc

Role: Associate

Site: CDL-Seattle

Stream: Computational Health

Jonathan Drachman is an experienced clinician, researcher, and biopharmaceutical executive who has spent 20 years in the biotech industry. From 2018-2023 he served as co-founder and CEO of Neoleukin Therapeutics. For 14 years prior, Jonathan was at Seattle Genetics, where he served in a variety of roles, culminating in chief medical officer and executive vice president of research and development. From 1998 to 2004, Dr. Drachman was a faculty member of the division of hematology at the University of Washington in Seattle, and a senior investigator in the division of research and education at Puget Sound Blood Center. He currently serves on the board of directors for Harpoon Therapeutics and Abacus Biosciences. Dr. Drachman received a bachelor’s in biochemistry from Harvard University and an MD from Harvard Medical School. He completed his residency in internal medicine and fellowship in medical oncology at the University of Washington.